Fidelity Drug Patent Portfolio
Fidelity owns 1 orange book drug protected by 2 US patents Given below is the list of Fidelity's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12042484 | Tizanidine liquid preparation and use thereof | 07 May, 2042 | Active |
| US12263158 | Tizanidine liquid preparation and use thereof | 07 May, 2042 | Active |
Latest Legal Activities on Fidelity's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Fidelity.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail Patent eCofC Notification | 13 May, 2025 | US12263158 |
| Patent eCofC Notification | 13 May, 2025 | US12263158 |
| Recordation of Patent eCertificate of Correction | 13 May, 2025 | US12263158 |
| Email Notification | 13 May, 2025 | US12263158 |
| Post Issue Communication - Certificate of Correction | 30 Apr, 2025 | US12263158 |
| Post Issue Communication - Certificate of Correction | 21 Apr, 2025 | US12263158 |
| Recordation of Patent Grant Mailed | 01 Apr, 2025 | US12263158 |
| Patent Issue Date Used in PTA Calculation | 01 Apr, 2025 | US12263158 |
| Recordation of Patent eGrant | 01 Apr, 2025 | US12263158 |
| Email Notification | 01 Apr, 2025 | US12263158 |
| Mail Patent eGrant Notification | 01 Apr, 2025 | US12263158 |
| Patent eGrant Notification | 01 Apr, 2025 | US12263158 |
| Email Notification | 13 Mar, 2025 | US12263158 |
| Issue Notification Mailed | 12 Mar, 2025 | US12263158 |
| Dispatch to FDC | 01 Mar, 2025 | US12263158 |
Fidelity's Family Patents
Fidelity Drug List
Given below is the complete list of Fidelity's drugs and the patents protecting them.
1. Ontralfy
Ontralfy is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12042484 | Tizanidine liquid preparation and use thereof |
07 May, 2042
(16 years from now)
| Active |
| US12263158 | Tizanidine liquid preparation and use thereof |
07 May, 2042
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ontralfy's drug page